Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Ruifeng Wang
Introduction
Ruifeng Wang is a notable inventor based in Harbin, China. He has made significant contributions to the field of molecular imaging, particularly in evaluating liver regeneration capacity after surgical procedures. His work is essential for advancing medical practices and improving patient outcomes.
Latest Patents
Ruifeng Wang holds a patent for a molecular imaging method designed to evaluate liver regeneration capacity following the ALPPS operation. This innovative method involves several steps, including preparing a VX2 rabbit liver cancer model, performing ALPPS, synthesizing 18F-Fluoromethylcholine (18F-Methylcholine, 18F-FCH), and conducting PET/CT imaging along with data processing. This patent is groundbreaking as it is the first to utilize 18F-FCH PET/CT to monitor the proliferative capacity of residual liver tissue, thereby providing critical insights into liver regeneration.
Career Highlights
Ruifeng Wang is affiliated with Harbin Medical University, where he continues to engage in research and development in the field of molecular imaging. His work not only enhances the understanding of liver regeneration but also contributes to the clinical selection of ALPPS, helping to determine the optimal timing for subsequent surgeries.
Collaborations
Ruifeng Wang collaborates with esteemed colleagues, including Xilin Sun and Zhen Quan. Their combined expertise fosters a productive research environment that drives innovation in medical imaging and liver surgery.
Conclusion
Ruifeng Wang's contributions to molecular imaging and liver regeneration are invaluable to the medical community. His innovative patent and collaborative efforts at Harbin Medical University highlight the importance of research in improving surgical outcomes.